K Nagaoka, M Shirai, K Taniguchi, A Hosoi… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Although immune checkpoint blockade is effective for several malignancies, a
substantial number of patients remain refractory to treatment. The future of immunotherapy …